Factors governing the healing of Staphylococcus aureus infections following hip and knee prosthesis implantation: A retrospective study of 95 patients

Orthopaedics and Traumatology: Surgery and Research

Volumn 97, Issue 7, 2011, Pages 685-692

  Joulie, D ^b   Girard, J ^a,b   Mares, O ^b   Beltrand, E ^c   Legout, L ^c   Dezeque H ^b   Migaud, H ^a,b   Senneville, E ^c  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b UNIV LILLE   (France)

^c Tourcoing Hospital   (France)

Author keywords

Antibiotics; Debridement; Hip prosthesis; Knee prosthesis; One stage revision; Sepsis; Total joint infection; Two stage revision

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATION; CONTROLLED STUDY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; HUMAN; INFECTIOUS ARTHRITIS; LAVAGE; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; PREOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REOPERATION; RETROSPECTIVE STUDY; RISK; SCAR; STAPHYLOCOCCUS INFECTION; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; WOUND HEALING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; DEVICE REMOVAL; FEMALE; HIP PROSTHESIS; HUMANS; KNEE PROSTHESIS; MALE; MIDDLE AGED; PROGNOSIS; PROSTHESIS-RELATED INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; YOUNG ADULT;

EID: 82455188270     PISSN: None     EISSN: 18770568     Source Type: Journal    
DOI: 10.1016/j.otsr.2011.05.013     Document Type: Article

References (32)

1. Lecuire F., Gontier D., Carrere J., Giordano N., Rubini J., Basso M. Ten-year surveillance of nosocomial surgical site infections in an orthopedic surgery department. Rev Chir Orthop 2003, 89:479-486.
2. Berbari E.F., Hanssen A.D., Duffy M.C., Steckelberg J.M., Ilstrup D.M., Harmsen W.S., et al. Risk factors for prosthetic joint infection: case-control study. Clin Infect Dis 1998, 27:1247-1254.
3. Debarge R., Nicolle M.C., Pinaroli A., Ait Si Selmi T., Neyret P. Surgical site infection after total knee arthroplasty: a monocenter analysis of 923 first-intention implantations. Rev Chir Orthop 2007, 93:582-587.
4. Salgado C.D., Dash S., Cantey J.R., Marculescu C.E. Higher risk of failure of methicillin-resistant Staphylococcus aureus prosthetic joint infections. Clin Orthop Relat Res 2007, 461:48-53.
5. Walls R.J., Roche S.J., O'Rourke A., McCabe J.P. Surgical site infection with methicillin-resistant Staphylococcus aureus after primary total hip replacement. J Bone Joint Surg (Br) 2008, 90:292-298.
6. Vielpeau C., Lortat Jacob A. Les reprises de prothèses totales de hanche infectées. Rev Chir Orthop 2002, 88(Suppl):S161-S208.
7. Zimmerli W., Frei R., Widmer A.F., Rajacic Z. Microbiological tests to predict treatment outcome in experimental device-related infections due to Staphylococcus aureus. Antimicrob Chemother 1994, 33:959-967.
8. Tsukayama D.T., Estrada R., Gustilo R.B. Infection after total hip arthroplasty. A study of the treatment of one hundred and six infections. J Bone Joint Surg (Am) 1996, 78:512-523.
9. Senneville E., Savage C., Nallet I., et al. Improved aero-anaerobe recovery from infected prosthetic joint samples taken from 72 patients and collected intraoperatively in Rosenow's broth. Acta Orthop 2006, 77:120-124.
10. Barberán J., Aguilar L., Carroquino G., Giménez M.J., Sánchez B., Martínez D., et al. Conservative treatment of staphylococcal prosthetic joint infections in elderly patients. Am J Med 2006, 119(993):e7-e10.
11. Brandt C.M., Duffy M.C., Berbari E.F., Hanssen A.D., Steckelberg J.M., Osmon D.R. Staphylococcus aureus prosthetic joint infection treated with prosthesis removal and delayed reimplantation arthroplasty. Mayo Clin Proc 1999, 74:553-558.
12. Raut W., Siney P.D., Wroblewski B.M. One-stage revision of infected total hip replacements with discharging sinuses. J Bone Joint Surg (Br) 1994, 76:721-724.
13. Silva M., Tharani R., Schmalzried T.P. Results of direct exchange or debridement of the infected total knee arthroplasty. Clin Orthop Relat Res 2002, 404:125-131.
14. Van den Bekerom M.P., Stuyck J. The value of preoperative aspiration in the diagnosis of an infected prosthetic knee: a retrospective study and review of literature. Acta Orthop Belg 2006, 72:441-447.
15. Duff G.P., Lachiewicz, Kelley S.S. Aspiration of the knee joint before revision arthroplasty. Clin Orthop Relat Res 1996, 331:132-139.
16. Spangehl M.J., Masri B.A., O'Connell J.X., Duncan C.P. Prospective analysis of preoperative and intraoperative investigations for the diagnosis of infection at the sites of two hundred and two revision total hip arthroplasties. J Bone Joint Surg (Am) 1999, 81:672-683.
17. Blaser J., Vergères P., Widmer A.F., Zimmerli W. In vivo verification of in vitro model of antibiotic treatment of device-related infection. Antimicrob Agents Chemother 1995, 39:1134-1139.
18. Luessenhop C.P., Higgins L.D., Brause B.D., Ranawat C.S. Multiple prosthetic infections after total joint arthroplasty risk factor analysis. J Arthroplasty 1996, 11:862-868.
19. Choong P.F., Dowsey M.M., Carr D., Daffy J., Stanley P. Risk factors associated with acute hip prosthetic joint infections and outcome of treatment with a rifampin based regimen. Acta Orthop 2007, 78:755-765.
20. Lai K., Bohm E.R., Burnell C., Hedden D.R. Presence of medical comorbidities in patients with infected primary hip or knee arthroplasties. J Arthroplasty 2007, 22:651-656.
21. Peersman G., Laskin R., Davis J., Peterson M. Infection in total knee replacement. A retrospective review of 6489 total knee replacements. Clin Orthop Relat Res 2001, 392:15-23.
22. Garvin K.L., Hanssen A.D. Infection after total hip arthroplasty. Past, present, and future. J Bone Joint Surg (Am) 1995, 77:1576-1588.
23. Segawa H., Tsukayama D.T., Kyle R.F., Becker D.A., Gustilo R.B. Infection after total knee arthroplasty. A retrospective study of the treatment of eighty-one infections. J Bone Joint Surg (Am) 1999, 81:1434-1445.
24. Harwood P.J., Talbot C., Dimoutsos M., Sunderland G., Shaw D., Wilcox M.H., et al. Early experience with linezolid for infections in orthopaedics. Injury 2006, 37:818-826.
25. Drancourt M., Stein A., Argenson J.N., Zannier A., Curvale G., Raoult D. Oral rifampin plus ofloxacin for treatment of staphylococcus-infected orthopedic implants. Antimicrob Agents Chemother 1993, 37:1214-1218.
26. Jackson W.O., Schmalzried T.P. Limited role of direct exchange arthroplasty in the treatment of infected total hip replacements. Clin Orthop Relat Res 2000, 381:101-105.
27. Sanzén L., Carlsson A.S., Josefsson G., Lindberg L.T. Revision operations on infected total hip arthroplasties. Two-to nine-year follow up study. Clin Orthop Relat Res 1988, 229:165-172.
28. Darley E.S., MacGowan A.P. Antibiotic treatment of Gram-positive bone and joint infections. J Antimicrob Chemother 2004, 53:928-935.
29. Stengel D., Bauwens K., Sehouli J., Ekkernkamp A., Porzsolt F. Systematic review and meta-analysis of antibiotic therapy for bone and joint infections. Lancet Infect Dis 2001, 1:175-188.
30. Lazzarini L., Lipsky B.A., Mader J.T. Antibiotic treatment of osteomyelitis: what have we learned from 30 years of clinical trials?. Int J Infect Dis 2005, 9:127-138.
31. Moran E., Masters S., Berendt A.R., McLardy-Smith P., Byren I., Atkins B.L. Guiding empirical antibiotic therapy in orthopaedics: the microbiology of prosthetic joint infection managed by debridement, irrigation and prosthesis retention. J Infect 2007, 55:1-7.
32. Legout L., Valette M., Dezeque H., et al. Tolerability of prolonged linezolid therapy in bone and joint infection: protective effect of rifampicin on the occurrence of anaemia?. J Antimicrob Chemother 2010, 65:2224-2230.